Back to Trades
Brumm Joshua T
Chief Executive OfficerDirectorCIK 0001528826
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2025–2026
Brumm Joshua T, Chief Executive Officer, Director, has filed 4 SEC reports (2025–2026), all concentrated in CRESCENT BIOPHARMA, INC. (CBIO), totaling $7.9M in disclosed volume. Weighing $0 bought versus $920.8K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Sep 18 | CBIO CRESCENT BIOPHARMA, INC. | Brumm Joshua T | Chief Executive Officer, Director | Sell | $159.8K |
| Jun 23 | CBIO CRESCENT BIOPHARMA, INC. | Brumm Joshua T | Chief Executive Officer, Director | Sell | $761.1K |
| Dec 17 | CBIO CRESCENT BIOPHARMA, INC. | Brumm Joshua T | Chief Executive Officer, Director | Grant | $2.4M |
| Dec 10 | CBIO CRESCENT BIOPHARMA, INC. | Brumm Joshua T | Chief Executive Officer, Director | Award | $4.6M |
4 filings